Based on the new NLEM, the government on Thursday notified the Drug (Price Control) Amendment Order, 2016. It has about 820 formulations. There were 628 formulations under the Drug Price Control Order (DPCO) of 2013, notified in the wake of the NLEM of 2011.
By law, the government has to issue a new price control order – and the National Pharmaceutical Pricing Authority (NPPA) needs to subsequently set their ceiling prices - whenever there is a new NLEM. The NPPA, say officials, would decide in two to three months. Currently, it has set the ceiling prices of 530 drugs of the 628 formulations in DPCO, 2013. Of the 530, a price reduction of above 40 per cent has happened in 126 medicines; those of another 34 have come down by 35-40 per cent.
“The regulator has reduced the price of 26 medicines by 30-35 per cent, while prices of 49 drugs have been reduced by 25-30 per cent,” said minister of state for chemicals Hansraj Ahir in a reply to a question in Parliament earlier this month.
While the prices of 65 medicines have been reduced by 20-25 per cent, 43 medicines have seen a cut of 15-20 per cent, he'd added.
NPPA is mandated to fix or revise prices of controlled bulk drugs and formulations, and to enforce prices and availability of medicines in the country, beside monitoring prices of decontrolled drugs, to keep these at reasonable levels.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)